CVS Health
CVS
1,815 hedge funds and large institutions have $58.2B invested in CVS Health in 2020 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 828 increasing their positions, 711 reducing their positions, and 143 closing their positions.
54% more call options, than puts
Call options by funds: $1.82B | Put options by funds: $1.18B
16% more repeat investments, than reductions
Existing positions increased: 828 | Existing positions reduced: 711
1.04% less ownership
Funds ownership: 77.26% → 76.22% (-1%)
2% less funds holding
Funds holding: 1,861 → 1,815 (-46)
21% less capital inflows, than outflows
Capital inflows: $2.83B | Capital outflows: $3.6B
22% less first-time investments, than exits
New positions opened: 111 | Existing positions closed: 143
45% less funds holding in top 10
Funds holding in top 10: 85 → 47 (-38)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$408M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$214M |
| 3 |
BlackRock
New York
|
+$195M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$158M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$155M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$708M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$247M |
| 3 |
Credit Suisse
Zurich,
Switzerland
|
-$122M |
| 4 |
Goldman Sachs
New York
|
-$112M |
| 5 |
Davenport & Co
Richmond,
Virginia
|
-$95.9M |
CVS Hedge Fund Activity: Q3 2020 in Review
1,815 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2020, worth a combined $58.2B — down 11% from $65.6B a quarter earlier.
Sellers outnumbered buyers: 143 funds closed out of CVS and 111 opened new positions — a net loss of 32 holders — while 711 trimmed existing stakes and 828 added.
The largest buyer was Capital World Investors, adding an estimated $408M. The largest seller was Capital International Investors, cutting an estimated $708M.
- 1,815 institutional investors held CVS Health (CVS) as of Q3 2020, down from 1,861 in Q2 2020.
- Funds reported $58.2B of CVS Health stock for Q3 2020, down 11% quarter-over-quarter.
- 111 funds opened new CVS Health positions in Q3 2020 and 143 closed out, a net change of -32 holders.
- The largest CVS Health buyer in Q3 2020 was Capital World Investors, an estimated $408M added.
- The largest CVS Health seller in Q3 2020 was Capital International Investors, an estimated $708M sold.
Based on aggregated 13F filings for Q3 2020.